STOCKS TELEGRAPH

Category: Mid Day Movers

  • Tomorrow Is Not Likely To Be Same For JinkoSolar (JKS)

    JinkoSolar Holding Co. Ltd. (JKS) is rising on the charts today, up 11.04% to trade at $45.57 at last check. Shares in JinkoSolar (JKS) closed the last trading day at $41.04. The volume of shares traded was 2.25 million, which is higher than the average volume over the last three months of 1.22 million. During the trading session, the stock oscillated between $39.00 and $42.22.

    JinkoSolar (JKS) had an earnings per share ratio of 0.18. JKS’s stock has lost -9.66% of its value in the previous five sessions and moved -4.93% over the past one month, but has lost -10.70% on year-to-date basis. The stock’s 50-day moving average of $48.08 is above the 200-day moving average of $46.99. Moreover, the stock is currently trading at RSI of 50.66. JKS stock is surging following an IPO move.

    Which IPO move JKS has made?

    JinkoSolar (JKS) is one of the biggest and most imaginative sun based module producers on the planet. JKS circulates its sunlight based items and offers its answers and administrations to an enhanced global utility, business and private client base in China, the United States, Japan, Germany, the United Kingdom, Chile, South Africa, India, Mexico, Brazil, the United Arab Emirates, Italy, Spain, France, Belgium, and different nations and locales.

    JKS has constructed an in an upward direction coordinated sun oriented item esteem chain, with an incorporated yearly limit of 31 GW for mono wafers, 19 GW for sun based cells, and 36 GW for sun based modules, as of September 30, 2021.

    JinkoSolar (JKS) today declared that the Company’s chief working auxiliary, Jinko Solar Co., Ltd. (“Jiangxi Jinko”), has finished its initia public offering (“IPO”) process.

    • JKS auxiliary additionally begun exchanging on the Shanghai Stock Exchange’s Sci-Tech development board (SSE, code: 688223) on January 26, 2022.
    • Jiangxi Jinko has given 2,000,000,000 shares addressing around 20% of the absolute 10,000,000,000 shares outstanding after the IPO.
    • The offers were given at a public contribution cost of RMB5.00 per share and the complete gross returns of the IPO are roughly RMB10.00 billion.
    • After the IPO, JinkoSolar (JKS) possesses roughly 58.62% of Jiangxi Jinko.
    • On the primary exchanging day of January 26, 2022, Jiangxi Jinko’s shares concluded at RMB10.55 per share, up 111.00% when contrasted with the IPO cost.

    How this will assist JKS with developing?

    As JinkoSolar (JKS) proceeds to scale and develop, approaching capital will support its intensity as the organization influences is organization and assets gathered over the course of the years to fortify its driving situation in the worldwide PV industry. Looking forward, JKS is hoping to accomplish ceaseless development and is focused on making supportable incentive for all nearby just as worldwide investors.

  • Investors Should Take Note Of Allscripts Healthcare (MDRX)

    At last check in current trading, shares of Allscripts Healthcare Solutions Inc. (MDRX) were up 16.28% at $20.33. Allscripts Healthcare (MDRX) stock closed last session at $17.48. Shares of the company were fluctuating between $16.85 and $17.53. The number of shares of MDRX stock exchanged on the day was 5.02 million, greater than the company’s 50-day daily volume of 1.51 million and higher than its Year to date volume of 1.03 million.

    In the past 12 months, Allscripts Healthcare (MDRX) stock has advanced 2.55%, and in the last one week, the stock has moved down -2.24%. For the last six months, the MDRX stock has gained a total of 1.39%, and over the last three months, the stock has increased by 26.67%. The stock has returned -5.26% so far this year. MDRX stock is surging after release of preliminary financial results.

    How remained MDRX in the announced quarter?

    Allscripts Healthcare (MDRX) is an innovator in medical services data innovation arrangements that advance clinical, monetary and functional outcomes. The creative arrangements by MDRX interface individuals, spots and information across an Open, Connected Community of Health. Through MDRX, network enables parental figures to settle on better choices and convey better consideration for better populaces.

    Allscripts Healthcare (MDRX) today reported primer monetary outcomes for the three and a year finished December 31, 2021.

    • MDRX’s income for the final quarter of 2021 is relied upon to be between $390 million and $395 million.
    • For the entire year 2021, MDRX expects GAAP working pay to be between $70 million and $75 million.
    • Allscripts Healthcare (MDRX) likewise anticipates that its Adjusted EBITDA should be between $295 million and $300 million, an increment from the earlier viewpoint scope of between $275 million and $285 million.
    • MDRX expects entire year 2021 income from proceeding with activities to be between $245 million and $250 million.
    • MDRX’s assumption for the free income is to be between $165 million and $170 million, an increment from the earlier standpoint scope of between $145 million and $155 million.

    Share buyback plan:

    Allscripts Healthcare (MDRX) likewise reported that its Board of Directors has endorsed another share repurchase program under which MDRX might buy up to $250 million of its not common stock. The new share repurchase program doesn’t have an end date and replaces the past approval to repurchase up to $350 million of common stock. In the final quarter of 2021, MDRX repurchased $108 million of its common stock, and this completely used all excess approval under the earlier program.

    When MDRX will report the full outcomes?

    Allscripts Healthcare (MDRX) will report its monetary outcomes for the three and a year finished December 31, 2021 after the end of securities exchange hours on Thursday, February 24, 2022. MDRX the executives intends to have a telephone call and webcast to examine the organization’s income at 4:30 p.m. Eastern Time that very day.

  • Inpixon (INPX): Are Investors Missing The Big Picture?

    Inpixon (INPX) has advanced 4.69% at $0.44 in current market on the last check Tuesday. The stock of INPX completed the previous trading session at $0.42. The price range of the INPX shares was between $0.40 and $0.45. INPX stock traded 0.27 million shares, which was below its daily average of 1.71 million shares over 100 days. INPX’s shares have dropped by -18.31% in the last five days, while they have lost -37.31% in the last month. INPX stock is surging following signing of a contract.

    INPX entered the agreement for what?

    Inpixon (INPX) is the trailblazer of Indoor Intelligence, conveying noteworthy bits of knowledge for individuals, spots and things. Joining the force of planning, situating and investigation; INPX assists with making more brilliant, more secure, and safer conditions. The organization’s Indoor Intelligence and versatile application arrangements are utilized by a huge number of enterprises to upgrade tasks, increment efficiency, and improve security.

    Inpixon (INPX) clients can exploit industry driving area mindfulness, RTLS, working environment and cross breed occasion arrangements, examination, sensor combination and the IoT to make outstanding encounters and to accomplish something beneficial with indoor information.

    Inpixon (INPX) last Tuesday reported that it has contracted with a head car vehicle maker. INPX went into the agreement to give its savvy office application to use at a few of their work environment areas including the U.S. corporate central command grounds and different global areas. The arrangement incorporates direct front proficient administrations expenses and repeating income permit charges adding up to the greater part 1,000,000 dollars over the underlying three-year term.

    INPX accepts the new customer picked the Inpixon savvy office application to assist with improving the worker experience, animate joint effort, and empower more robotized and paperless cycles across the customer’s worldwide organization of workplaces.

    Representatives of this Inpixon (INPX) client will actually want to use their customer marked Android and iOS applications for the usefulness including for review ongoing work area accessibility maps; performing work area and room-booking that is coordinated with the worker index and server schedules; adding virtual gathering joins by means of a Zoom mix to work with cross breed gatherings.

    They could likewise involve with INPX for finding and exploring to wanted objections or associates utilizing Inpixon guides and blue-spot situating; conveying by means of the Slack profound connections joining, message pop-ups, studies and live surveys; and determining neighborhood grounds data including eating, health, conveniences, nearby lodging facilities and transportation.

    How INPX will benefit customer’s management team?

    The Inpixon (INPX) arrangement will be available for the outwardly weakened and incorporates an investigation dashboard for the executives to see office limit and space usage reports. INPX’s versatile application is planned to upgrade the representative experience while giving simpler admittance to data and colleagues to at last work with a more secure and more associated labor force.

  • Why Tuniu Corporation (TOUR) stock is green today?

    Why Tuniu Corporation (TOUR) stock is green today?

    Shares of the Tuniu Corporation (TOUR) stock was green in the current market trading session today on January 25, 2022. TOUR stock price saw a push of 1.01% to reach $1.20 a share at the time of this writing. The trading volume on the last check was 296,449, lower than the average trading volume.

    Tuniu Corporation is operating as an online leisure travel company in the People’s Republic of China. The company offers many packaged tours including organized and self-guided tours along with other travel-related services. TOUR stock has a market cap of $146.9 million and a 544,070 average trading volume.

    What’s Happening with TOUR stock?

    There is no press release or any announcement by the company associated with the rise in the per-share price of this stock. No analyst has upgraded or increased the per-share target price of TOUR stock in recent times. It seems that the stock is rising due to some external factors. The sentiment in the social media platforms is positive, pushing this stock in the upward direction. So, what do you need to know now at this moment? Let’s discuss some recent events of this stock.

    Senior Management Share Purchase Plan:

    Tuniu announced on December 27, 2021, that certain management members and employees of the company wish to purchase Tuniu’s American Depository Shares (ADS). The management members include Mr. Donald Dunde Yu, founder, and CEO of the company, Mr. Wei Zhang, Vice president, and Mr. Anqiang Chen, financial controller. These members and certain employees will use personal funds to purchase ADS up to a maximum of US$2 million within the next six months.

    Financial View of TOUR stock:

    In the third quarter of 2021, the company reported a revenue of RMB114.6 million. This represents a decrease of 7.2% year-over-year from the same period of 2020. Tuniu reported RMB74.9 million cost of revenues in the third quarter of 2021, a 28.1% high from the same period of 2020. Gross profit declined by 38.9% to drop at RMB39.7 million. The net loss of the TOUR stock was RMB36.6 million in the last reported quarter, as compared to RMB62.1 million in the same period of the previous year.

    The operating expenses of the company totaled RMB96.4 million in the third quarter of 2021. These include RMB15.6 million R&D expenses, RMB41.7 million-selling, and marketing expenses, and RMB41.2 million G&A expenses. By the end of the third quarter of 2021, the company had RMB1.0 billion in cash, cash equivalents, and short-term investments.

  • IMARA Inc. (IMRA) stock falls today: What’s going on?

    IMARA Inc. (IMRA) stock falls today: What’s going on?

    Shares of the IMARA Inc. (IMRA) were falling in the current market trading session today on January 25, 2022. IMRA stock price saw a downtrend of 3.18% to drop at $1.52 a share at the time of this writing. The stock was also gloomy in the previous trade and went down by 6.55% at closing.

    IMARA Inc., a clinical-stage biopharmaceutical firm mainly working for patients suffering from rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, which is in the Phase 2b clinical trial to treat thalassemia and sickle cell. IMRA stock has a market cap of $41.25 million and 173,541 average trading volume. Let’s understand the current bearish momentum.

    What’s Happening with IMRA stock?

    IMARA Inc today announced the clearance of its new drug application for tovinontrine (IMR-687) by the U.S Food and Drug Administration. The company applied to start clinical development to treat heart failure with preserved ejection fraction (HFpEF). The company is anticipating the Phase 2 trial in the second quarter of the ongoing year. IMARA will evaluate the tovinontrine in patients who are older than 45 years with persistent HFpEF symptoms. Though the news is positive but did not change the sentiment among investors in the stock market. IMARA stock reached an all-time low at $1.52 so far.

    Clinical Update:

    Back on November 22, 2021, the company announced that it has changed the primary endpoint for the Ardent Phase 2b clinical trial of tovinontrine. The company took this step after getting feedback from the U.S Food and Drug Administration. The fetal hemoglobin (HbF) response was the previous primary endpoint for the Ardent trial. FDA after reviewing the Ardent draft recommended annualized rate of vaso-occlusive crises as the primary endpoint, which was previously the key secondary endpoint.

    Financial View of IMRA stock:

    On November 9, 2021, IMARA announced the financial results for the third quarter ended September 30, 2021, according to which

    The company spent $10.4 million in research and development expenses in the third quarter of 2021. These expenses were $9.5 million in the same tenure as the previous year. The general and administrative expenses of the IMRA reached $3.3 million in the last reported quarter. This represents an increase of $0.3 million from the same period of 2020. The company suffered a $13.6 million net loss attributable to common stockholders or $0.55 per share of IMRA stock. By the end of the third quarter, the company had $102.8 million in cash, cash equivalents, and investments.

  • When Will Document Security Systems (DSS) Will Start Recovering

    When Will Document Security Systems (DSS) Will Start Recovering

    Document Security Systems Inc. (DSS) has plunged -18.53% at $0.37 in the current market on the last check Monday. The stock of Document Security Systems (DSS) completed the previous trading session at $0.46. The price range of DSS shares was between $0.45 and $0.55. It traded 1.65 million shares, which was above its daily average of 1.05 million shares over 100 days. DSS shares have dropped by -30.69% in the last five days, while they have lost -36.44% in the last month. DSS stock continued the decline to shun the gain it has achieved after an acquisition move.

    What does Document Security Systems has gained?

    Document Security Systems is a global organization working business sections in blockchain security, direct showcasing, medical services, customer bundling, land, environmentally friendly power, securitized advanced resources, protections exchanging and reserve the executives, and banking, loaning, and money.

    The plan of action of Document Security Systems depends on a dissemination sharing framework in which investors get shares in its auxiliaries as DSS decisively opens esteem through IPO side projects. Under new initiatives starting around 2019, DSS has fabricated the vital establishment for economical development through the procurement and arrangement of an expanded arrangement of organizations situated to drive benefit in five high-development areas.

    Document Security Systems last week went into a stock buy arrangement (the “AIL Subscription Agreement”) on January 18, 2022,

    • DSS consented to the arrangement with its investor Alset EHome International Inc. (“AEI”), which at present claims 15.24% of the Company’s extraordinary shares of common stock.
    • In accordance with AIL Subscription Agreement, AEI offered to DSS 877,248,065 norma shares, no par value, of Alset International Limited at a buy cost of 59,979,582 recently issued shares of the Company’s normal stock.
    • Following the end of this exchange, AEI will possess 55.52% of remarkable portions of normal stock and will be the larger part investor of Document Security Systems.
    • On January 18, 2022, Document Security Systems went into a stock buy arrangement (the “True Partners Subscription Agreement”) with AEI.
    • Compliant with that understanding, AEI offered to DSS 100 percent of the shares of common stock of its completely claimed auxiliary True Partner International Limited (HK) (“TP”).
    • AEI will likewise sold DSS every one of TP’s 62,122,908 common shares of True Partner Capital Holding Limited (“True Partner”), at a buy cost of 11,397,080 recently issued shares of the Company’s common stock.

    How might DSS get the advantage of these arrangements?

    Document Security Systems is investigating the capability of its protections business and these speculations will assist with speeding up the development of this and other key portions. DSS has made its Securities to be a central part of the protections, money, and asset the board area. The current moves will left DSS with ownership of more than 25% of Alset International.

  • Is the Rough Ride Over for ShiftPixy (PIXY)

    Is the Rough Ride Over for ShiftPixy (PIXY)

    At last check in current trading, shares of ShiftPixy Inc. (PIXY) were up 27.42% at $1.58. ShiftPixy (PIXY) stock closed last session at $1.24. Shares of PIXY were fluctuating between $1.104 and $1.35. The number of shares of PIXY stock exchanged on the day was 25.16 million, greater than the company’s 50-day daily volume of 6.13 million and higher than its Year to date volume of 8.57 million.

    In the past 12 months, ShiftPixy stock has retreated -63.20%, and in the last week, the stock has moved up 18.10%. For the last six months, the PIXY stock has lost a total of -31.11%, and over the last three months, the stock has increased by 9.73%. PIXY stock has returned 5.98% so far this year. PIXY stock is rocketing following an NFT program.

    What NFT plan ShiftPixy has been doing?

    ShiftPixy (PIXY) gives disruptive human resources platform, changing work in the Gig Economy. PIXY conveys a cutting edge versatile commitment innovation to assist organizations with shift-based representatives explore administrative commands, limit regulatory weights and better interface with a prepared available labor force.

    With aptitude established in administration’s inexact 25 years of laborers’ pay and consistence programs insight, ShiftPixy adds a required layer for tending to consistence and preceded with requests for evenhanded business rehearses in the developing Gig Economy.

    ShiftPixy (PIXY) today declared the advancement of a vigorous non-fungible token (NFT) gamification unwaveringness program. Imp intends to deliver it in 2022 as the Company gets ready for the send off of its Ghost Kitchen food brands.

    • With more than 40 million individuals traveling through the metaverse consistently, an increment in robotic apparatuses, and positive feeling around apparition kitchens, PIXY has set out a freedom to lift the café business and bring about another period of feasting.
    • By utilizing PIXY’s mechanical skill, this can carefully span actual distances progressively among loved ones through a completely vivid, blended reality experience worked for the present computerized assumptions.
    • ShiftPixy means for its brands to inundate shoppers into an expanded and blended reality experience that will test each custom and inheritance in buyer promoting.
    • This will show the world a high-esteem use case for adapting the metaverse.
    • Pushing ahead with this undertaking, PIXY intends to expand its contributions and lift its impression in the computerized world.
    • The NFT Loyalty program is relied upon to consolidate Web, In-App Gamification, and Augmented Reality (AR) attached to mark NFTs.
    • NFTs will be accessible to customers that pursue PIXY’s food image requesting applications.

    How PIXY will use NFT?

    ShiftPixy is planning the NFT Loyalty program to permit purchasers to bring their custom NFT into the in-application games to dominate rewards and free food things. Once effectively executed, purchasers at PIXY will actually want to encounter the AR NFTs through interesting QR codes inside the NFT profiles of each separate symbol in the assortment.

  • Why Happiness Development Group Limited (HAPP) stock is down today?

    Shares of the Happiness Development Group Limited (HAPP) stock were gloomy in the current market trading session today on January 21, 2022. HAPP stock price saw a decline of 6.68% to drop at $0.48 a share at the time of this writing. The trading volume on the last check was 474,494, lower than the average trading volume. Let’s have a deep look at this stock.

    Happiness Development Group Limited is operating as the research, developer, and manufacturer as well as seller of nutraceutical and dietary supplement products in China. HAPP stock has a market cap of $16.29 million and a 541,820 average trading volume.

    What’s Happening?

    The current bearish momentum of the HAPP stock is the result of the announcement of a $10 million private placement by the company. Happiness Development today announced that it has signed the security purchase agreement with several non-U.S. strategic investors. According to the agreement, the company will sell 12,500,000 Class A ordinary shares at $0.80 per share price. This represents a 45% premium to the market price of its Class A ordinary shares.

    The company is planning to use net proceeds from the offering in the expansion of its eCommerce sales around the globe. The company also intends to add more products to its eCommerce stores. Part of the proceeds is intended to use for the working capital and general corporate purposes.

    Financial Results of HAPP stock

    Company on January 6, 2022, announced financial results for the six months ended September 30, 2021. In this tenure, the company generated $46.88 million in revenues. This represents a whopping increase of $25.01 million or 114.3% from the same tenure of the previous year. The increase is attributable to the start-up of new goods.

    The operating loss in the six months ended September 30, 2021, for the HAPP stock, was $10.53 million. This operating loss was $14.22 million in the same period of the previous year. The performance in the healthcare products segment resulted in this decline.

    Net loss attributable to the shareholders of the HAPP stock was $ 10.05 million in the six months ended September 30, 2021. In the same tenure of the previous year, the company reported $3.19 million net income attributable to the shareholders of HAPP stock.

    Wrap Up

    The announcement of the private placement is the obvious reason for the decline in HAPP stock. In the last six months, this stock has lost approximately 67%.

  • Why is Tonix Pharmaceuticals Holding Corp. (TNXP) stock gloomy today?

    Shares of the Tonix Pharmaceuticals Holding Corp. (TNXP) stock were declining in the current market trading session today on January 21, 2022. TNXP stock price saw a decline of 8.20% to drop at $0.23 a share at the time of this writing. The stock was also gloomy in the previous trading session and went down by 6.49% at closing. Let’s take a closer look at this stock

    Tonix Pharmaceuticals Holding Corp is a healthcare company that is discovering and developing small molecules to prevent human diseases and alleviate suffering. TNXP stock has a market cap of $125.15 million and a 16,509,559 average trading volume.

    What’s Happening?

    TNXP stock has lost the attention of investors in the stock market after rising for a certain time period today. The sentiment about this stock is not positive, causing the decline in the per-share price in the current market.

    The positive fact about the company is that it is developing TNX-1800, which has shown a great immune response against SARS-CoV-2. The rapidly spreading Omicron is making headlines in the whole world despite the rollout of many vaccines. The nature of the Omicron is very much different from the previous mutations of Covid-19. The vaccines in the market are efficient in neutralizing the antibodies but do not generate a robust T-cell response. The company TNX-1800 is based on its horsepox vector platform. Orthopoxviruses show strong innate and adaptive immune responses along with long-lasting T cell immunity.

    Recent news of TNXP stock

    On January 11, 2022, the company announced that it has enrolled the first participant in the dose-finding study for TNX-2100. It is an in vivo skin test that measures the delayed-type hypersensitivity (DTH) to SARS-CoV-2.  The company is measuring functional T cell immunity via DTH. The management thinks that the TNX-2100 skin test has the potential to meet the needs of the rapid, sensitive, and specific test associated with SARS-CoV-2.

    Financial View of TNXP stock

    In the third quarter of 2021, the company spent $13.1 million in research and development expenses. These expenses were $8.8 million in the same tenure of the previous year. The company spent $5.5 million in general and administrative expenses in the third quarter of 2021, higher than the previous year’s G&A expenses. Net loss of the common stockholders of TNXP stock was $18.5 million, or $0.05 per share, basic and diluted in Q3,2021. The company ended the quarter with $183.0 million in cash and cash equivalents.

  • Why Digital Brands Group, Inc. (DBGI) stock is rising today?

    Shares of the Digital Brands Group, Inc. (DBGI) stock were rising in the current market trading session today on January 20, 2022. DBGI stock price saw a push of 3.00% to reach $1.37 a share at the time of this writing. The trading volume on the last check was 5,142,431, higher than the average trading volume. Let’s take a closer look to understand the reason behind this bull.

    What’s Happening with DBGI stock?

    DBGI stock has captivated the attention of investors in the current market after the company announced the acquisition of Sundry. Digital Brand Group today announced that it has entered into the definitive merger agreement under which it will acquire Sundry, which is a privately-owned global lifestyle apparel brand. The company expects to complete the transaction in the first of the ongoing year subject to financing and customary closing conditions.

    Highlights of Sundry Acquisition

    • DBGI expects that this acquisition will positively impact the revenues and internal cash flows because of the shared expenses in both marketing and operations.
    • The acquisition will increase brand awareness as well as customer demand. This will help the company in its future growth, a good sign for the shareholders of DBGI stock.
    • Another goal which company expects to achieve through this acquisition is to create significant synergies between all its portfolio. This will result in low customer acquisition costs, customer retention and annual spending per customer as well as higher lifetime value.

    Financial View of DBGI stock

    The company on January 7, 2022, provided a net revenue update for the fourth quarter and fiscal 2021. The company also reaffirmed previously announced 2022 net revenue and EBITDA guidance. Digital Brands expects that its fourth-quarter revenue will come in line with its previously forecasted revenue of approximately $4.0 million. The company reported that the global supply chain disruptions have slightly impacted the revenue.

    The company expects that its revenue for the fiscal year 2021 will increase by 44% to $7.6 million. The previous year’s revenue was $5.2 million for the DBGI stock. The company has not recognized the revenue from Harper & Jones or Stateside for the fiscal year 2021. It is because these brands were acquired during the fiscal year 2021.

    Outlook

    The company reaffirmed the previous guidance of $37.5 million to $42.5 million for the fiscal year 2022. This represents the whooping growth of 350% from the fiscal year 2021 net revenue. In a nutshell, DBGI stock can be a good bet for long-term investors.